Zhejiang Shengda receives falling revenue from biotin and folic acid sales

Summary: According to Zhejiang Shengda's H1 2018 financial report, both its revenue and net profit decreased over H1 2017. The reason is the bad performance in the biotin and folic acid sectors.On 16 Aug., Zhejiang Shengda Bio-pharm Co., Ltd. (Zhejia...

Vitamins China E-News 1808

www.cnchemicals.com